Liyi Yu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

2. Results and Discussion 2.1. Experiment Setup and Evaluation In this work, we are more concerned with new drugs not in the known DDI network, that is, drugs that have never been involved in model training. There are two goals for the DDI prediction task: the interactions between known drugs and new drugs (Task 1) and the interactions between new drugs (Task 2). These are known as the cold-start scenario.

Abstract : Adverse drug reactions (ADRs) are a major issue to be addressed by the pharmaceutical industry. Early and accurate detection of potential ADRs contributes to enhancing drug safety and reducing financial expenses. The majority of the approaches that have been employed to identify ADRs are limited to determining whether a drug exhibits an ADR, rather than identifying the exact type of ADR.